NWLS Transfers Marketing License Relating to Innovative Topical Drug Delivery to Atlan International

New Life Scientific, Inc. (OTCBB: NWLS), a company which specializes in the development of new biotechnology products and pharmaceuticals, announced today that it has transferred marketing rights to Atlan International(OTC: ATLI) of license agreement for two platform technologies (patent pending)... - February 27, 2007

PharmaTrials Announces Expansion Plan into Asia

Pharma Trials International, Inc. a subsidiary of New Life Scientific, Inc. (OTCBB: NWLS), specializes in providing clinical trial services, market research, and services to enable pharmaceutical, biotech and medical device companies worldwide to conduct research and to obtain regulatory approval... - February 01, 2007

New Life Scientific Moves into New Headquarters

New Life Scientific, Inc (NWLS) a developmental biotech company whose core focus is to develop and commercialize novel biotech/pharmaceutical products including vaccines and stem cell based treatment modalities and to expand through our own research, collaborations, acquisitions and in-licensing,... - September 01, 2006

New Life Scientific Enters New Phase

New Life Scientific, Inc (NWLS), today announced that at the special meeting of the Board of Directors a decision was made to re-evaluate its current progress and review its future options being considered include reviewing opportunities to acquire, license, and/or joint venture various medical,... - April 11, 2006

New Life Scientific, Inc. and Telomolecular Corp Announce Strategic Alliance Agreement

New Life Scientific, Inc. (OTCBB:NWLF - News) and Telomolecular Corp, have announced a strategic alliance to develop products that treat aging and age-related disease. New Life Scientific, Inc a company engaged in developing pharmaceutical products as well as managing PharmaTrials International... - December 05, 2005

Press Releases 1 - 5 of 5